Thomas M. McAusland

Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer

Lisa A. Santry, Thomas M. McAusland, Leonardo Susta et al. · Molecular Therapy — Methods & Clinical Development · 2017 · 40 citations · Full text

Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer

Jacob P. van Vloten, Kathy Matuszewska, Mark A.A. Minow et al. · Journal for ImmunoTherapy of Cancer · 2022 · 28 citations · Full text

Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models

Thomas M. McAusland, Jacob P. van Vloten, Lisa A. Santry et al. · Molecular Therapy — Oncolytics · 2021 · 26 citations · Full text

Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies

Jacob P. van Vloten, Lisa A. Santry, Thomas M. McAusland et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 18 citations · Full text

Interference chromatography: a novel approach to optimizing chromatographic selectivity and separation performance for virus purification

Lisa A. Santry, Renaud Jacquemart, Melissa Vandersluis et al. · BMC Biotechnology · 2020 · 13 citations · Full text